Stada rises on market talk of bid by Teva
FRANKFURT (Reuters) - Shares in German generic drugmaker Stada Arzneimittel (STAGn.DE) rose as much as 4 percent as traders pointed to market talk that larger rival Teva (TEVA.TA) could make an offer at 42 euros ($56.78) per share.
The shares were up 1.6 percent at 35.51 euros at 1421 GMT on Tuesday, more than two hours ahead of the market close, with trading volumes at more than twice the one-day average over the past three months.
Stada and Teva declined to comment.
- First Ebola victim in Sierra Leone capital on the run
- Former WWE champ nabs suspected burglar in Arizona
- Apple iPhones allow extraction of deep personal data, researcher finds
- China's Guangdong province removes over 850 'naked officials' from their posts
- EU edges to economic sanctions on Russia but narrows scope |